Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 431
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals. A...

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based meal...

How to edit any gene.

Imagine being able to edit any gene—from Alzheimer's and cancer to eye color and balding. Today, that is almost...

Backer Badge Funded